Seramun Diagnostica GmbH - Company Review
Seramun Diagnostica GmbH - Company ReviewSummary
Seramun Diagnostica GmbH (Seramun) is a healthcare products provider that develops and manufactures in vitro diagnostics and reagents. The company offers substrates, detection systems, stabilizers, antibodies, LIA kits, ELISA kits, and control ELISA kits. It provides services such as antibody production, antibody purification, antibody conjugation, peptide synthesis and assay development. Seramun also develops seraline scan software. The company’s ELISA kits are used for the treatment of thyroid autoimmune diseases, systemic autoimmune diseases, anti-phospholipid syndrome, rheumatic diseases, human proteins and antibodies and others diseases. It markets its products across Germany. Seramun is headquartered in Heidesee, Germany.
This comprehensive company report of Seramun Diagnostica GmbH provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.